11:15 PM
 | 
Aug 09, 2018
 |  BC Week In Review  |  Financial News  |  Completed Offerings

Novo Holdings leads Therachon's $60M round

Rare disease company Therachon AG (Basel, Switzerland) said on Aug. 9 it completed a $60 million mezzanine financing led by new investor Novo Holdings.

Fellow new investors Cowen Healthcare Investments, Pfizer Ventures and funds managed by Tekla Capital Management participated, as did existing investors...

Read the full 197 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >